A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial. [electronic resource]
Producer: 20020131Description: 551-5 p. digitalISSN:- 0277-3732
- Adult
- Aged
- Aged, 80 and over
- Aminopterin -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Recombinant Proteins
- Remission Induction
- Sickness Impact Profile
- Survival Analysis
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.